Hongyang Li
Chinese Academy Of Medical Sciences &Peking Union Medical College
Nanjing, China
Nanjing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Targeting the creatine transporter SLC6A8: Mechanisms and emerging therapeutic strategies for multiple diseases.
Journal: Biochemical pharmacology
Published: April 16, 2026
Sappanone A exerted promising therapeutic effects in vitiligo through Wnt5a-mediated noncanonical Wnt signaling.
Journal: Journal of natural medicines
Published: March 03, 2026
Current insights into the metabolic dysregulation of keratinocytes in psoriasis: A review.
Journal: Journal of dermatological science
Published: February 02, 2026
Single-cell RNA sequencing provides insights into the potential cellular origins and microenvironment of Extramammary Paget's disease.
Journal: Clinical immunology (Orlando, Fla.)
Published: November 22, 2025
Solute carrier family 15 member 4, an emerging therapeutic target for systemic lupus erythematosus.
Journal: International reviews of immunology
Published: April 21, 2025
Implication of Immunobiological Function of Melanocytes in Dermatology.
Journal: Clinical reviews in allergy & immunology
Published: March 03, 2025
Sappanone A Exerted Strong Anti-Inflammatory Effects in the Treatment of Atopic Dermatitis Through IL-21R-Mediated JAK1/STAT3 Pathway.
Journal: Phytotherapy research : PTR
Published: December 29, 2024
Food effects and pharmacokinetic evaluation of oral single-dose prednisone acetate and prednisolone in healthy Chinese subjects.
Journal: BMC pharmacology & toxicology
Published: July 30, 2024
Linear hypermelanosis in narrow bands: a mosaic pattern manifestation of dyskeratosis congenita?
Journal: The British journal of dermatology
Published: July 15, 2024
Sappanone A ameliorated imiquimod-induced psoriasis-like dermatitis in BALB/c mice via suppressing Mmp8 expression and IL-17 signaling pathway.
Journal: European journal of pharmacology
Published: April 02, 2024
A rationally designed CD19 monoclonal antibody-triptolide conjugate for the treatment of systemic lupus erythematosus.
Journal: Acta pharmaceutica Sinica. B
Published: March 03, 2024
Last Updated: 09/26/2026